
Enable job alerts via email!
Generate a tailored resume in minutes
Land an interview and earn more. Learn more
A leading cancer research institute in Singapore is seeking a Data Scientist to support omics research and big data analysis. The role involves managing large datasets, executing computational pipelines, and collaborating with clinicians and researchers. Candidates should have a Master's/PhD and at least 3 years of experience in a Genomics-related field. This position offers opportunities for substantial impact on cancer research through innovative data analyses and systems management.
NCCS Data and Computational Science (DCS) is a newly established computational hub within National Cancer Center of Singapore (NCCS) which focuses on leveraging data analytics and computational methods to advance cancer research and treatment. DCS features high-powered computing resources capable of processing ‘big data’ profiles and running advanced interpretable machine learning algorithms and robust statistical techniques. DCS offers in-house and centralised solutions for NCCS researchers who require computational analysis without the need to buy specialised equipment or contract with third party vendors.
DCS aims to maximise the efficiency of data processes and accelerate research outcomes. With access to national level medical data spanning clinical, imaging and omics datasets, our efforts are concentrated on harvesting the innate value of these rich datasets to improve cancer patient care and treatment delivery through the production of world‑class research.
The Data Scientist will provide support and insights for DCS core multi‑omics research and big data analysis computing infrastructure that focus on using next‑generation sequencing (NGS), radiological imaging and other multi‑modal datatypes to develop biomarkers predictive of clinical responses in cancer patients. The Data Scientist will be expected to wrangle and manage large datasets, execute computational pipelines and interpret data to better understand the complexity of cancer progression and treatment resistance across multiple cancer types, as well as design new pipelines and/or optimise existing ones to meet evolving research needs.